Forskningsoutput per år
Forskningsoutput per år
Forskningsoutput
- 5 resultat
Sökresultat
-
2021
Adjuvant imatinib for GIST: duration likely matters
Eriksson, M. & Joensuu, H., 2021, I: Annals of Oncology. 32, 4, s. 434-436Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial
-
2019
Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated with Preoperative Imatinib
Eriksson, M. & Joensuu, H., 2019, I: Clinical Oncology and Research. 2, 5, s. 1-2Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial › Peer review
Öppen tillgång -
2003
Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures?
Hardell, L. & Eriksson, M., 2003, I: Environmental Health Perspectives. 111, 14, s. 1704-1706Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial › Peer review
-
1991
The association between cancer mortality and dioxin exposure: A comment on the hazard of repetition of epidemiological misinterpretation
Hardell, L. & Eriksson, M., 1991 jan. 1, I: American Journal of Industrial Medicine. 19, 4, s. 547-549Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial › Peer review
-
1990
Exposure to dioxins as a risk factor for soft tissue sarcoma: A population - based case-control study
Eriksson, M., Hardell, L. & Adami, H. O., 1990 mars 21, I: Journal of the National Cancer Institute. 82, 6, s. 486-490Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial › Peer review